April 8, 2022
Neuropsychotropic Drug Therapy 2021 | New Medications in Movement Disorders
Neuropsychotropic Drug Therapy 2021
New Medications in Movement Disorders
Shu-Ching Hu, MD, PhD
Movement Disorder Neurologist, Associate Professor of Neurology, University of Washington, Seattle
For psychiatric nurse practitioners, clinical nurse specialists, nurses, pharmacists and other interested healthcare professionals.
Objectives for Learning Outcomes
At the conclusion of this activity, participants will be better able to:
- Gain knowledge on the updates of Tardive Dyskinesia and its treatment.
- Describe new medications for Parkinson’s Disease.
- Describe new medications for non-motor symptoms of Parkinson’s Disease.